jumps on EMA approval for new rivaroxaban drug. Shares of Shilpa Medicare Limited hit a 5 percent upper circuit, after EMA granted initial authorisation for medicinal products in Europe, unlocking a $2.5 billion market opportunity. With a market cap of Rs. 8,025 crores, the shares of Shilpa Medicare Limited hit a 5 percent upper circuit at Rs. 858.1 on BSE, as against its previous closing price of Rs. 817.25. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.